Serum Neurofilament Light Chain and Cardiovascular Outcomes in Patients With Atrial Fibrillation

20260 citationsJournal Articlegreen Open Access

Authors

Geethan Baskaran · University of Toronto

Philipp Krisai · University of Basel

Michael Kühne · University of Basel

Stefanie Aeschbacher · University of Basel

Jens Kuhle · University of Basel

Pascal B. Meyre · University of Basel

Michael Coslovsky ·

Abstract

After multivariable adjustment, sNfL levels were associated with a broad range of adverse cardiovascular events and mortality in patients with AF. Serum NfL may serve as a biomarker of cardiovascular risk in patients with AF.

Topics & Keywords

Atrial Fibrillation Management and Outcomes Intracerebral and Subarachnoid Hemorrhage Research Blood properties and coagulation

UN Sustainable Development Goals

Reduced inequalities

Publication Details

Published in: JAMA Cardiology

DOI: 10.1001/jamacardio.2026.0922

Field-Weighted Citation Impact: 0.00